PDCD1 and neoplasm: Antibody blockade of PD-1 or PD-L1 has been shown to be beneficial in reducing tumor volumes and mediating antitumor immune responses in these humanized PD-1/PD-L1 mouse models, which parallels effects observed in patients25,26.